An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study) - Normandie Université Access content directly
Journal Articles Health Science Reports Year : 2023

An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study)

Dates and versions

hal-03932613 , version 1 (10-01-2023)

Identifiers

Cite

Benoît Dupont, Olivier Dejardin, Véronique Bouvier, Marie-Astrid Piquet, Arnaud Alves. An observational, prospective, multicenter study on the utilization and effectiveness of elbasvir–grazoprevir treatment association for chronic hepatitis C in France (ZEPHYR study). Health Science Reports, 2023, 6 (1), pp.819-835. ⟨10.1002/hsr2.619⟩. ⟨hal-03932613⟩
20 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More